http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2042032-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f79749e86afce9444a364ab60ca3584 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1990-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fbcde30384331bfcda738963a05f06e |
| publicationDate | 1995-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2042032-C |
| titleOfInvention | Therapeutic agent and method of inhibiting vascularization of tumors |
| abstract | A method and therapeutic agent for at least partially inhibiting vascularization of a developing solid tumor. The therapuetic agent comprises polysacchridetoxin, a GBS toxin, produced by group B .beta.-hemolytic Streptococcus bacteria. The GBS agent is in a purified, toxin-active form which can be parenterally administered in an amount effective for vascularization inhibition. |
| priorityDate | 1989-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.